Baker McKenzie Switzerland, along with lawyers from the London and Amsterdam office, has advised Zur Rose Group on the placement of convertible bonds due 2026 and a capital increase through an accelerated bookbuilding (“ABB“) process. Zur
Tags :Tanja Schmid
Baker McKenzie Switzerland, along with other Baker McKenzie offices, advised Feintool International Holding (“Feintool”) on its capital increase by approximately CHF 202 million via a rights offering. UBS acted as sole global coordinator and bookrunner while
SEBA Bank (“SEBA”) successfully completes its Series C funding round, raising CHF 110 million through the issuance of participation certificates (non-voting shares). The financing round was co-led by a consortium of specialized blockchain and fintech investors,
The first Swiss SPAC, VT5 Acquisition Company, successfully priced its initial public offering. The listing of the Class A Shares and Redeemable Warrants on
Zur Rose Group, e-commerce pharmacy and medical wholesalers, has concluded its accelerated bookbuilding (ABB) with the issuance of 650’000 new shares at an offer price of CHF 290 and gross proceeds of CHF 188.5 million. The shares were
Varia US Properties, a Swiss-based real estate company investing exclusively in US multifamily housing with a focus on secondary and tertiary markets, has successful issued a CHF 50 million fixed-rate bond with a coupon of 2.875% and
Cosmo Pharmaceuticals and Cassiopea have entered into a transaction agreement under which Cosmo is launching a public exchange offer in Switzerland to acquire all of the publicly-held registered shares of Cassiopea. The public exchange offer
Baker McKenzie advised UBS in all legal, regulatory and competition law aspects of the transaction. The team was led by Ansgar Schott (Financial Services - pictured left), Pascal Richard (pictured second left) and Petra Hanselmann (
Deutsche Börse Group’s post-trade services provider Clearstream and Ubs have agreed on a partnership in the investment fund services business segment.
